Clinical Trial Update: Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial reports systemic exposure to catechins from Veregen 15% ointment in patients with external anogenital warts and from oral green tea beverage …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Warts

Drugs mentioned

• Green tea beverage (green tea (Camellia sinensis) beverage)
• Veregen 15% Ointment (sinecatechin)

Snippet

Sponsor: MediGene | Conditions: Anogenital Warts | Phase 1 | Status: COMPLETED